Canada markets open in 1 hour 31 minutes

ADC Therapeutics SA (ADCT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
4.4500-0.4500 (-9.18%)
At close: 04:00PM EDT
4.4700 +0.02 (+0.45%)
Pre-Market: 07:59AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
69,558
69,558
209,908
33,917
0
Cost of Revenue
2,529
2,529
3,301
1,393
0
Gross Profit
67,029
67,029
206,607
32,524
0
Operating Expenses
Research Development
127,127
127,127
186,457
158,002
142,032
Selling General and Administrative
105,888
105,888
143,494
136,242
77,231
Total Operating Expenses
232,080
232,080
329,594
293,878
218,679
Operating Income or Loss
-165,051
-165,051
-122,987
-261,354
-218,679
Interest Expense
46,325
46,325
36,731
18,340
4,926
Total Other Income/Expenses Net
5,417
5,417
10,333
28,123
-23,190
Income Before Tax
-195,419
-195,419
-146,817
-251,505
-245,963
Income Tax Expense
39,106
39,106
227
-21,479
327
Income from Continuing Operations
-240,053
-240,053
-157,128
-230,026
-246,290
Net Income
-240,053
-240,053
-157,128
-230,026
-246,290
Net Income available to common shareholders
-240,053
-240,053
-157,128
-230,026
-246,290
Basic EPS
-2.18
-
-2.01
-3.00
-3.77
Diluted EPS
-2.18
-
-2.01
-3.00
-3.77
Basic Average Shares
81,260
-
78,153
76,748
65,410
Diluted Average Shares
81,260
-
78,153
76,748
65,410